
Shorter elapsed time in recent years shows encouraging improvement

Meanwhile, Congress strategizes repealing Obamacare, which expanded the 340b program

Healthcare providers occupy top three slots

Only 20 new molecular entities passed muster this year, less than half of 2015’s total

Added locations—as well as new product offerings—from Pelican Biothermal

New consumer-education campaign led by Alliance for Safe Online Pharmacies

A preamble for a next round of legislating drug pricing?

Action is expected to meet FTC objections to the merged chains announced in 2015

Just released survey details lack of consensus and difficulties with current requirements

Back to square one in addressing high-cost-drug spending

First branded-product discount program from Blink Health

HDA’s latest Factbook tracks temperature-controlled distribution


Higher productivity and more complexity; but slow takeup of traceability requirements

Strong growth of existing clients and new product introductions are justification

Growth rates will moderate in the US and world


Company offers to significantly undercut the pricing of sales force automation competitors

Goldman Sachs jumps in, takes a board seat

Direct-to-patient trial supply and protocol management from Center Point

The end of SSFFCs?

Bills passes House with broad bipartisan support; Senate approval likely

A counterargument to the belief that out-of-pocket expenses originate with insurers or PBMs

Sale comes with multi-year supply agreement

Two Canadian Accucaps facilities join global network of 11 Catalent RP Scherer Softgel locations

A standard, a user guidance and a business vocabulary; not for pharma applications alone

Better integration of treatment with overall healthcare delivery is sought

Bracket acquires CLINapps

Rxight program from MD Labs identifies gene-based drug interactions